World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
85
Citations
30081
World Ranking
14498
National Ranking
1338

Overview

Ruth Tal-Singer is affiliated with GlaxoSmithKline in the United Kingdom. Their research contributions focus notably on pulmonary and respiratory medicine, with a substantial number of publications in the field of medicine overall.

Their key subfields of study include:

  • Pulmonary and Respiratory Medicine
  • Physiology
  • Epidemiology
  • Emergency Medical Services
  • Molecular Biology

Their work covers several important topics, such as:

  • Chronic Obstructive Pulmonary Disease (COPD) Research
  • Asthma and respiratory diseases
  • Respiratory Support and Mechanisms
  • Pediatric health and respiratory diseases
  • Cardiovascular and exercise physiology
  • Respiratory and Cough-Related Research
  • Inhalation and Respiratory Drug Delivery

Ruth Tal-Singer has published frequently in the following venues:

  • American Journal of Respiratory and Critical Care Medicine
  • Chronic Obstructive Pulmonary Diseases Journal of the COPD Foundation
  • ERJ Open Research
  • Respiratory Research
  • International Journal of COPD

Some of their recent papers include:

  • Inflammatory Endotype-associated Airway Microbiome in Chronic Obstructive Pulmonary Disease Clinical Stability and Exacerbations: A Multicohort Longitudinal Analysis, 2020, American Journal of Respiratory and Critical Care Medicine
  • The sputum microbiome, airway inflammation, and mortality in chronic obstructive pulmonary disease, 2020, Journal of Allergy and Clinical Immunology
  • Multi-ancestry genome-wide association analyses improve resolution of genes and pathways influencing lung function and chronic obstructive pulmonary disease risk, 2023, Nature Genetics
  • Machine Learning and Prediction of All-Cause Mortality in COPD, 2020, CHEST Journal
  • Chronic obstructive pulmonary disease and related phenotypes: polygenic risk scores in population-based and case-control cohorts, 2020, The Lancet Respiratory Medicine

Ruth Tal-Singer collaborates often with several researchers, including:

  • Bruce E. Miller
  • Edwin K. Silverman
  • Stephen I. Rennard
  • Brian D. Hobbs
  • Divya Mohan

Best Publications

  • Susceptibility to Exacerbation in Chronic Obstructive Pulmonary Disease

    John R. Hurst;Jørgen Vestbo;Jørgen Vestbo;Antonio Anzueto;Nicholas Locantore

  • Characterisation of COPD heterogeneity in the ECLIPSE cohort

    Àlvar Agustí;Peter Ma Calverley;Bartolome R Celli;Harvey O Coxson

  • Changes in forced expiratory volume in 1 second over time in copd

    Jørgen Vestbo;Jørgen Vestbo;Lisa D. Edwards;Paul D. Scanlon;Julie C. Yates

  • Persistent systemic inflammation is associated with poor clinical outcomes in COPD: a novel phenotype.

    Alvar Agustí;Lisa D. Edwards;Stephen I. Rennard;William MacNee

  • Evaluation of COPD Longitudinally to Identify Predictive Surrogate End-points (ECLIPSE).

    J Vestbo;W Anderson;H O Coxson;C Crim

  • New genetic signals for lung function highlight pathways and chronic obstructive pulmonary disease associations across multiple ancestries

    Shrine N;Guyatt Al;Erzurumluoglu Am;Jackson Ve;Jackson Ve;Jackson Ve

  • Inflammatory biomarkers improve clinical prediction of mortality in chronic obstructive pulmonary disease.

    Bartolome R. Celli;Nicholas Locantore;Julie Yates;Ruth Tal-Singer

  • Comorbidity, systemic inflammation and outcomes in the ECLIPSE cohort.

    Joy Miller;Lisa D Edwards;Alvar Agustí;Per Bakke

  • Eosinophilic inflammation in COPD: prevalence and clinical characteristics

    Dave Singh;Umme Kolsum;Chris E. Brightling;Nicholas Locantore

  • Identification and Initial Characterization of Four Novel Members of the Interleukin-1 Family

    Sanjay Kumar;Peter C. McDonnell;Ruth Lehr;Lauren Tierney

  • Variants in FAM13A are associated with chronic obstructive pulmonary disease

    Michael H. Cho;Nadia Boutaoui;Barbara J. Klanderman;Jody S. Sylvia

  • Genetic loci associated with chronic obstructive pulmonary disease overlap with loci for lung function and pulmonary fibrosis

    Brian D. Hobbs;Kim De Jong;Maxime Lamontagne;Yohan Bossé

  • Lung microbiome dynamics in COPD exacerbations

    Zhang Wang;Mona Bafadhel;Koirobi Haldar;Koirobi Haldar;Aaron Spivak

  • Genetic landscape of chronic obstructive pulmonary disease identifies heterogeneous cell-type and phenotype associations

    Phuwanat Sakornsakolpat;Phuwanat Sakornsakolpat;Dmitry Prokopenko;Dmitry Prokopenko;Maxime Lamontagne;Nicola F Reeve

  • Risk loci for chronic obstructive pulmonary disease: a genome-wide association study and meta-analysis

    Michael H Cho;Merry-Lynn N McDonald;Xiaobo Zhou;Manuel Mattheisen;Manuel Mattheisen

  • Six-minute-walk test in chronic obstructive pulmonary disease: minimal clinically important difference for death or hospitalization.

    Michael I. Polkey;Martijn A. Spruit;Lisa D. Edwards;Michael L. Watkins

  • Serum surfactant protein D is steroid sensitive and associated with exacerbations of COPD.

    D A Lomas;E K Silverman;L D Edwards;N W Locantore

  • The presence and progression of emphysema in COPD as determined by CT scanning and biomarker expression: a prospective analysis from the ECLIPSE study

    Harvey O. Coxson;Asger Dirksen;Lisa D. Edwards;Julie C. Yates

  • Evaluation of serum CC-16 as a biomarker for COPD in the ECLIPSE cohort

    David A Lomas;Edwin K Silverman;Lisa D Edwards;Bruce E Miller

  • Genetic landscape of chronic obstructive pulmonary disease identifies heterogeneous cell-type and phenotype associations

    Phuwanat Sakornsakolpat;Dmitry Prokopenko;Maxime Lamontagne;Nicola F. Reeve

Frequent Co-Authors

Jørgen Vestbo
Jørgen Vestbo University of Manchester
Edwin K. Silverman
Edwin K. Silverman Brigham and Women's Hospital
David A. Lomas
David A. Lomas University College London
William MacNee
William MacNee University of Edinburgh
Emiel F.M. Wouters
Emiel F.M. Wouters Maastricht University
Alvar Agusti
Alvar Agusti University of Barcelona
Per Bakke
Per Bakke University of Bergen
Peter M.A. Calverley
Peter M.A. Calverley University of Liverpool
Bartolome R. Celli
Bartolome R. Celli Brigham and Women's Hospital
Michael I. Polkey
Michael I. Polkey National Institutes of Health

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re exploring options beyond a traditional pre-med or medicine program, there are several online degree and career pathways worth considering. For those seeking fast entry into the nursing profession without prior experience, online direct entry msn programs for non-nurses offer a streamlined transition to advanced nursing roles.

Applicants concerned about admission barriers can look at nursing schools with high acceptance rates, which may increase your chances of beginning a healthcare career. You might also bypass some of the stress of standardized testing by applying to a nursing school no entrance exam.

If you’re interested in the healthcare field but not direct patient care, consider accredited online programs in medical billing and coding. There are many medical billing and coding schools online that offer flexible learning options and access to financial aid.

Each of these pathways helps students enter vital medical fields through accessible education formats, giving you multiple ways to start your healthcare career.

Best Scientists Citing Ruth Tal-Singer

Trending Scientists